EXPRESSPIK
Diagnostic kits consisting primarily of reagents, namely, PCR reagents used to detect and measure levels of RNA with mutations
and normal copies of certain genes in human tumors, for targeting breast, hematological, colorectal, ovarian, head and neck, or
lung cancer or PROS (PIK3CA-related overgrowth syndrome) treatment eligibility, clinical prognosis determination or clinical
follow-up
Pending · September 23, 2024 · 98763930 ·